The Role of Cardiomyocyte Polarity in Cardiac Morphogenesis

心肌细胞极性在心脏形态发生中的作用

基本信息

  • 批准号:
    9212199
  • 负责人:
  • 金额:
    $ 41.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-02-01 至 2021-01-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The heart is the first organ to develop, a process that involves multiple cell fate decisions and morphological processes. Key among these is the orientation of specific morphological events such as trabeculation and septation toward the heart lumen. Failure of these processes can result in congenital heart disease, a major cause of mortality and morbidity. The objective of this proposal is to identify the mechanism whereby atypical Protein Kinase C Iota (Prkci) and the downstream PAR polarity machinery direct myocardial polarization at the single cell and whole organ levels. The central hypothesis is that directional cues from the endocardium and cardiac jelly direct Prkci and the Par complex to orient the spindle apparatus and the cell division plane of luminal myocardial toward the heart lumen and propel trabecular formation. This hypothesis has been formulated on the basis of strong preliminary data produced in the applicant's laboratory and is tested with three specific aims: 1) determine how Prkci directs cardiomyocyte proliferation and differentiation during ventricular trabeculation; 2) define the molecular mechanism through which Prkci controls the Par complex and the spindle machinery to regulate polarized cell division in luminal myocardial cells; and 3) define the non-cell autonomous inductive signaling cues that direct myocardial polarization. Under the first aim, single cell clonal analysis is performed to determine how Prkci directs oriented cell division. Highly innovative cell labeling and genome editing techniques are coupled with cutting-edge spectral confocal microscopy to define the role of Prkci-dependent polarized cell division in the initiation of trabeculation. In the second aim, the applicant determines how Prkci controls the downstream Par machinery and explores the potential of this pathway to direct polarized cell division in human stem cell derived myocytes. In the third aim, the applicant identifies the upstream inductive cues that feed into Prkci and its interacting partners and adapts the knowledge gained from developmental biology to stem cell biology. The rationale for these studies is that they are the first to address how the highly conserved PAR complex orients the mitotic spindle and axis of cell division to control myocardial alignment during in vivo cardiogenesis and in vitro cellular differentiation. The advent of stem cell based approaches to regenerative cardiology and the necessity of ensuring the proper cellular alignment of transplanted cells or constructs make this research highly significant. Thus, the overall impact of this project is to provide a mechanistic understanding of how the highly conserved Par machinery directs polarized cell division to control normal cardiac organogenesis. This study provides a fundamental understanding of a key morphological event in cardiac development that can be applied to regenerative cardiovascular medicine where it is necessary to expand the number of functional CMs and promote their alignment and cellular integration with the native myocardium.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IBRAHIM J DOMIAN其他文献

IBRAHIM J DOMIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IBRAHIM J DOMIAN', 18)}}的其他基金

Control of Cardiac Lineage Commitment and Differentiation in Murine Development
小鼠发育中心脏谱系承诺和分化的控制
  • 批准号:
    8238397
  • 财政年份:
    2010
  • 资助金额:
    $ 41.69万
  • 项目类别:
Control of Cardiac Lineage Commitment and Differentiation in Murine Development
小鼠发育中心脏谱系承诺和分化的控制
  • 批准号:
    8078886
  • 财政年份:
    2010
  • 资助金额:
    $ 41.69万
  • 项目类别:
Control of Cardiac Lineage Commitment and Differentiation in Murine Development
小鼠发育中心脏谱系承诺和分化的控制
  • 批准号:
    8650301
  • 财政年份:
    2010
  • 资助金额:
    $ 41.69万
  • 项目类别:
Control of Cardiac Lineage Commitment and Differentiation in Murine Development
小鼠发育中心脏谱系承诺和分化的控制
  • 批准号:
    8443831
  • 财政年份:
    2010
  • 资助金额:
    $ 41.69万
  • 项目类别:
Control of Cardiac Lineage Commitment and Differentiation in Murine Development
小鼠发育中心脏谱系承诺和分化的控制
  • 批准号:
    7894258
  • 财政年份:
    2010
  • 资助金额:
    $ 41.69万
  • 项目类别:

相似海外基金

The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
  • 批准号:
    10678248
  • 财政年份:
    2023
  • 资助金额:
    $ 41.69万
  • 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
  • 批准号:
    10681939
  • 财政年份:
    2023
  • 资助金额:
    $ 41.69万
  • 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
  • 批准号:
    10427574
  • 财政年份:
    2022
  • 资助金额:
    $ 41.69万
  • 项目类别:
Arginine regulation of alpha cell proliferation and function
精氨酸调节α细胞增殖和功能
  • 批准号:
    10609909
  • 财政年份:
    2022
  • 资助金额:
    $ 41.69万
  • 项目类别:
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosis
线粒体回补-回补对α细胞胰高血糖素分泌的调节
  • 批准号:
    10607392
  • 财政年份:
    2022
  • 资助金额:
    $ 41.69万
  • 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
  • 批准号:
    10675646
  • 财政年份:
    2022
  • 资助金额:
    $ 41.69万
  • 项目类别:
Elucidating alpha cell defects in human type 1 diabetes using precision cut pancreas slice-on-a-chip coupled with high spatio-temporal microscopy
使用精密切割的胰腺切片结合高时空显微镜阐明人类 1 型糖尿病的 α 细胞缺陷
  • 批准号:
    457552
  • 财政年份:
    2021
  • 资助金额:
    $ 41.69万
  • 项目类别:
    Studentship Programs
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
定义 2 型糖尿病治疗的 α 细胞胰高血糖素原加工过程
  • 批准号:
    10331361
  • 财政年份:
    2020
  • 资助金额:
    $ 41.69万
  • 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
  • 批准号:
    10623306
  • 财政年份:
    2020
  • 资助金额:
    $ 41.69万
  • 项目类别:
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
定义 2 型糖尿病的 α 细胞 PC1/3 表达调控
  • 批准号:
    10376866
  • 财政年份:
    2020
  • 资助金额:
    $ 41.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了